🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is conducted in Africa, Asia and North America. The aim of this ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2008-01
Trial ID
NCT00611884
Treatments Being Tested
This is a safety, tolerability, and pharmacokinetics study of bimatoprost i...
Status
Terminated
Location
DermResearch, LLC
Start Date
2016-03
Trial ID
NCT02676310
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
The primary purpose of the study is to investigate the safety, tolerability...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-09-12
Trial ID
NCT06033547
Treatments Being Tested
This is a randomized, placebo-controlled, parallel-group, multi-site, doubl...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00383435
The purpose of this study is to measure the pharmacokinetics (PK-how the bo...
Status
Recruiting
Location
Research Site
Start Date
2026-07-27
Trial ID
NCT07723833
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-31
Trial ID
NCT01678677
Treatments Being Tested
This study will assess up to 12 different oral formulations of apremilast t...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2014-01-07
Trial ID
NCT02236988
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-22
Trial ID
NCT01659086
Treatments Being Tested
The purpose of this clinical pharmacology study is to evaluate the CHF 6532...
Status
Completed
Location
SGS Life Sciences - Clinical Pharmacology Unit Antwerpen
Start Date
2019-05-10
Trial ID
NCT03942666
Treatments Being Tested